Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept |
| |
| Authors: | V. Bagalas I. Kioumis P. Argyropoulou D. Patakas |
| |
| Affiliation: | (1) Department of Pulmonary Disease, Aristotle University of Thessaloniki Medical School–“G. Papanikolaou” Hospital, Exohi, Thessaloniki, 57010, Greece |
| |
| Abstract: | Visceral leishmaniasis (VL) is a severe disease that can develop in immunocompromised patients. Antitumor necrosis factor-α (TNF-α) treatment of rheumatoid arthritis can result in clinical benefits, but with an increased risk of opportunistic infections. Leishmania infection in patients treated with TNF-α antagonists is extremely rare; for this reason, we report a patient with VL after etanercept treatment who had an unfavorable outcome. |
| |
| Keywords: | Etanercept Rheumatoid arthritis TNF-α antagonists Visceral leishmaniasis |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
